SWX:CLTN

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

COLTENE Holding AG develops, manufactures, and sells disposables, tools, and equipment for dentists and dental laboratories in Europe, the Middle East, Africa, North America, Latin America, and Asia/Oceania. More Details


Snowflake Analysis

Reasonable growth potential with adequate balance sheet.

Share Price & News

How has COLTENE Holding's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: CLTN is not significantly more volatile than the rest of Swiss stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: CLTN's weekly volatility (5%) has been stable over the past year.


Market Performance


7 Day Return

4.3%

CLTN

1.4%

CH Medical Equipment

0.3%

CH Market


1 Year Return

5.3%

CLTN

4.9%

CH Medical Equipment

0.5%

CH Market

Return vs Industry: CLTN matched the Swiss Medical Equipment industry which returned 4.9% over the past year.

Return vs Market: CLTN exceeded the Swiss Market which returned 0.5% over the past year.


Shareholder returns

CLTNIndustryMarket
7 Day4.3%1.4%0.3%
30 Day10.0%7.8%3.9%
90 Day33.1%15.9%12.4%
1 Year7.8%5.3%5.6%4.9%4.1%0.5%
3 Year6.4%-3.2%38.8%32.3%21.6%6.8%
5 Year69.6%44.1%122.4%106.1%52.4%27.5%

Long-Term Price Volatility Vs. Market

How volatile is COLTENE Holding's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is COLTENE Holding undervalued compared to its fair value and its price relative to the market?

14.5%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: CLTN (CHF92) is trading below our estimate of fair value (CHF107.65)

Significantly Below Fair Value: CLTN is trading below fair value, but not by a significant amount.


Price To Earnings Ratio

PE vs Industry: CLTN's PE Ratio (43.8x) is in line with the CH Medical Equipment industry average.

PE vs Market: CLTN is poor value based on its PE Ratio (43.8x) compared to the Swiss market (23.9x).


Price to Earnings Growth Ratio

PEG Ratio: CLTN is poor value based on its PEG Ratio (1.7x)


Price to Book Ratio

PB vs Industry: CLTN is overvalued based on its PB Ratio (7x) compared to the CH Medical Equipment industry average (6.2x).


Next Steps

Future Growth

How is COLTENE Holding forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?

25.4%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: CLTN's forecast earnings growth (25.4% per year) is above the savings rate (-0.3%).

Earnings vs Market: CLTN's earnings (25.4% per year) are forecast to grow faster than the Swiss market (12.8% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: CLTN's revenue (3.7% per year) is forecast to grow slower than the Swiss market (4.6% per year).

High Growth Revenue: CLTN's revenue (3.7% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: CLTN's Return on Equity is forecast to be high in 3 years time (26.1%)


Next Steps

Past Performance

How has COLTENE Holding performed over the past 5 years?

3.7%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: CLTN has high quality earnings.

Growing Profit Margin: CLTN's current net profit margins (5.1%) are lower than last year (7.4%).


Past Earnings Growth Analysis

Earnings Trend: CLTN's earnings have grown by 3.7% per year over the past 5 years.

Accelerating Growth: CLTN's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: CLTN had negative earnings growth (-34.1%) over the past year, making it difficult to compare to the Medical Equipment industry average (-34.1%).


Return on Equity

High ROE: CLTN's Return on Equity (15.8%) is considered low.


Next Steps

Financial Health

How is COLTENE Holding's financial position?


Financial Position Analysis

Short Term Liabilities: CLTN's short term assets (CHF138.0M) exceed its short term liabilities (CHF107.4M).

Long Term Liabilities: CLTN's short term assets (CHF138.0M) exceed its long term liabilities (CHF4.9M).


Debt to Equity History and Analysis

Debt Level: CLTN's debt to equity ratio (100.2%) is considered high.

Reducing Debt: CLTN's debt to equity ratio has increased from 20.3% to 100.2% over the past 5 years.

Debt Coverage: CLTN's debt is well covered by operating cash flow (30%).

Interest Coverage: CLTN earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Next Steps

Dividend

What is COLTENE Holding current dividend yield, its reliability and sustainability?

1.63%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: CLTN's dividend (1.63%) is higher than the bottom 25% of dividend payers in the Swiss market (1.62%).

High Dividend: CLTN's dividend (1.63%) is low compared to the top 25% of dividend payers in the Swiss market (3.81%).


Stability and Growth of Payments

Stable Dividend: CLTN's dividend payments have been volatile in the past 10 years.

Growing Dividend: CLTN's dividend payments have fallen over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonable payout ratio (71.4%), CLTN's dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: CLTN's dividends in 3 years are forecast to be covered by earnings (59.6% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

6.5yrs

Average management tenure


CEO

Martin Schaufelberger (56 yo)

8.58yrs

Tenure

CHF836,308

Compensation

Mr. Martin Schaufelberger has been the Chief Executive Officer of COLTENE Holding AG since June 1, 2012. Mr. Schaufelberger commands a long and very successful experience in leading mid-sized, companies op...


CEO Compensation Analysis

Compensation vs Market: Martin's total compensation ($USD942.38K) is about average for companies of similar size in the Swiss market ($USD1.20M).

Compensation vs Earnings: Martin's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Martin Schaufelberger
Chief Executive Officer8.58yrsCHF836.31k0.20%
CHF 1.1m
Gerhard Mahrle
Chief Financial Officer7yrsno data0.051%
CHF 282.5k
Stefan Helsing
Chief Operating Officer2.17yrsno data0.91%
CHF 5.0m
Werner Barth
Vice President of Product Management & Group Marketing6yrsno data0.026%
CHF 141.7k

6.5yrs

Average Tenure

59yo

Average Age

Experienced Management: CLTN's management team is seasoned and experienced (6.5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Erwin Locher
Non-Executive Director11.75yrsCHF80.44k0.092%
CHF 505.3k
Nick Huber
Independent Chairman of the Boardno dataCHF106.37k0.24%
CHF 1.3m
Matthew Robin
Independent Non-Executive Director15yrsCHF84.45k0.090%
CHF 493.6k
Roland Weiger
Independent Non-Executive Director7.75yrsCHF74.02k0.022%
CHF 122.2k
Jürgen Rauch
Independent Non-Executive Director5yrsCHF64.00k0.0068%
CHF 37.4k
Astrid Waser
Independent Non-Executive Director3.83yrsCHF74.02k0.0038%
CHF 20.9k
Allison Zwingenberger
Independent Non-Executive Director2.33yrsCHF72.89k0.00054%
CHF 3.0k

6.4yrs

Average Tenure

55yo

Average Age

Experienced Board: CLTN's board of directors are considered experienced (6.4 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

COLTENE Holding AG's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: COLTENE Holding AG
  • Ticker: CLTN
  • Exchange: SWX
  • Founded: 2005
  • Industry: Health Care Supplies
  • Sector: Healthcare
  • Market Cap: CHF549.752m
  • Shares outstanding: 5.98m
  • Website: https://www.coltene.com

Number of Employees


Location

  • COLTENE Holding AG
  • Feldwiesenstrasse 20
  • Altstätten
  • St. Gallen
  • 9450
  • Switzerland

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
CLTNSWX (SIX Swiss Exchange)YesRegistered SharesCHCHFJun 2006
M3ZDB (Deutsche Boerse AG)YesRegistered SharesDEEURJun 2006
CLHL.FOTCPK (Pink Sheets LLC)YesRegistered SharesUSUSDJun 2006
0QP7LSE (London Stock Exchange)YesRegistered SharesGBCHFJun 2006

Biography

COLTENE Holding AG develops, manufactures, and sells disposables, tools, and equipment for dentists and dental laboratories in Europe, the Middle East, Africa, North America, Latin America, and Asia/Oceani...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/01/26 18:05
End of Day Share Price2021/01/26 00:00
Earnings2020/06/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.